Learn More
Medchemexpress LLC Letrozole (Standard) | 112809-51-5 | C17H11N5 | 200 MG

Supplier: Medchemexpress LLC HY14248200MG
Letrozole (CGS 20267) is a potent, selective, reversible, and orally active non-steroidal inhibitor of aromatase, with an IC50 of 11.5 nM. It selectively inhibits estrogen biosynthesis and can be used for breast cancer research.
- Potent, selective, reversible, and orally active non-steroidal inhibitor of aromatase
- Selectively inhibits estrogen biosynthesis
- Used for breast cancer research
- Exhibits anti-tumor effects in rats
- Inhibits growth of MCF-7 epithelial breast cancer cells
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.